A primary endpoint is the main outcome measure used to evaluate the effectiveness or safety of an intervention in a clinical trial. It is typically a single, specific variable that is defined before the study begins and is considered the most important result for answering the primary research question.
The primary endpoint is usually used to calculate the sample size needed for the study and is the focus of the main statistical analysis. It should be clinically relevant, sensitive to the intervention being tested, and measurable in all or nearly all participants in the study.
The primary endpoint is crucial in clinical research as it provides a clear, predefined measure for assessing the success or failure of a study. It enables researchers to focus their efforts on collecting and analyzing the most critical data, ensuring that the study’s main objective is addressed effectively and efficiently.
Furthermore, the primary endpoint serves as a standardized benchmark for regulatory agencies, healthcare professionals, and other stakeholders to evaluate the clinical significance of study results. It allows for more consistent comparison across different studies and helps in the decision-making process regarding the approval, adoption, or further investigation of new treatments or interventions.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant